Cardiovascular
-
C9100 Tirabrutinib HClSummary: A selective irreversible BTK inhibitor for research in immunology and tumor biology. -
C9085 UNC2025 HClSummary: An ATP-competitive MERTK/FLT3 inhibitor suitable for in vitro and in vivo mechanistic studies. -
C9067 Cediranib MaleateSummary: A selective VEGFR tyrosine kinase inhibitor, for research use only. -
BA6355 KhellinSummary: A natural furochromone epidermal growth factor receptor (EGFR) inhibitor. -
C8918 Ritlecitinib (PF-06651600)Summary: Ritlecitinib (PF-06651600; CAS 1792180-81-4) is a selective covalent JAK3/TEC family kinase inhibitor used to investigate cytokine signaling and immune-cell pathway biology. -
C8914 FursultiamineSummary: Fursultiamine is a lipophilic thiamine derivative used to investigate vitamin B1 metabolism, thiamine-dependent enzymatic pathways, and cellular bioenergetics in biochemical research. -
C8845 Xanthinol NicotinateSummary: Xanthinol nicotinate is a vasoactive nicotinic acid ester modulating purinergic signaling and microcirculatory dynamics, utilized in cardiovascular physiology and cellular metabolism research. -
C6100 GlycineSummary: An inhibitory neurotransmitter for research on neurological diseases, cancer, and cytoprotection. -
A8980 Avitinib maleateSummary: A third-generation EGFR and BTK dual-target irreversible inhibitor with oral activity. -
C4419 NaphthofluoresceinSummary: Inhibitor of furin
